Article info

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Authors

  1. Correspondence to Dr Angel YS Wong, London School of Hygiene & Tropical Medicine, London, UK; angel.wong{at}lshtm.ac.uk
View Full Text

Citation

Wong AY, MacKenna B, Morton CE The OpenSAFELY Collaborative, et al
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Publication history

  • Received November 16, 2020
  • Revised January 8, 2021
  • Accepted January 8, 2021
  • First published January 21, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.